×
About 1,050 results

ALLMedicine™ Tinea Cruris Center

Research & Reviews  41 results

Real World Analysis of Response Rate and Efficacy of Oral Ketoconazole in Patients with...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733503
The American Journal of Tropical Medicine and Hygiene; Arora P, Sardana K et. al.

Oct 12th, 2021 - Recalcitrant dermatophytosis has had an alarming rise in India with concomitant decreased effectiveness of conventional antifungal agents. This has prompted the use of second-line agents for treatment. In this retrospective study, we aimed to anal...

Topical clotrimazole cream for the treatment of tinea cruris: A retrospective study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676513
Medicine Zhao D, Chen B et. al.

Nov 22nd, 2020 - This retrospective study assessed the efficacy and safety of 1% topical clotrimazole cream for the treatment of patients with tinea cruris (TC).We included 86 patients with confirmed TC for the presence of fungal hyphae. Of those, 43 patients rece...

A rare case of coexistence of autoimmune polyglandular syndrome type 3 with growth horm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557705
The Journal of International Medical Research; Zhou W, Lin H et. al.

Oct 14th, 2020 - Autoimmune polyglandular syndrome (APS) is a rare disease that is characterized by autoimmune reactions to multiple endocrine and non-endocrine organs, which can be divided into four main types. The principal manifestations of APS-3 are autoimmune...

Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-asso...
https://www.ncbi.nlm.nih.gov/pubmed/32898398
Dermatology Online Journal; Cohen PR, Erickson CP et. al.

Sep 9th, 2020 - Terbinafine is an antifungal agent used in the treatment of hair, nail, and skin dermatophyte infections. Skin side effects to terbinafine are not common. Lichenoid drug eruption is a medication-related adverse cutaneous event; the lesion morpholo...

see more →

Drugs  354 results see all →

Clinicaltrials.gov  3 results

Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris
https://clinicaltrials.gov/ct2/show/NCT02394340

Nov 27th, 2019 - This is an open-label, maximal use study to evaluate whether luliconazole in plasma acts as an inhibitor of cytochrome P2C19 (CYP2C19) as measured by circulating levels of omeprazole before and after treatment with a maximum dose of luliconazole c...

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
https://clinicaltrials.gov/ct2/show/NCT00750152

Apr 22nd, 2013 - To evaluate the efficacy and safety of NAFT-500, applied once daily for 2 weeks, compared to placebo in the treatment of subjects with potassium hydroxide (KOH) and culture positive symptomatic tinea cruris.

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
https://clinicaltrials.gov/ct2/show/NCT01349998

Jan 23rd, 2013 - The purpose of this study is to examine the long-term safety of treating recurrent episodes of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or tinea cruris for 7 days for each recurrence with Product 33525.

see more →

News  17 results

Expert reviews strategies for diagnosing, treating onychomycosis
https://www.mdedge.com/familymedicine/article/211923/hair-nails/expert-reviews-strategies-diagnosing-treating-onychomycosis?channel=39313
MDedge Dermatology; Doug Brunk

Nov 8th, 2019 - LAS VEGAS – The way Neal Bhatia, MD, sees it, there is no such thing as a classical presentation of onychomycosis. Doug Brunk/MDedge News Dr.

Expert reviews strategies for diagnosing, treating onychomycosis
https://www.mdedge.com/dermatology/article/211923/hair-nails/expert-reviews-strategies-diagnosing-treating-onychomycosis
Doug Brunk

Nov 8th, 2019 - LAS VEGAS – The way Neal Bhatia, MD, sees it, there is no such thing as a classical presentation of onychomycosis. Doug Brunk/MDedge News Dr.

Tinea Incognito in an Urban Pediatric Population
https://www.mdedge.com/dermatology/article/178666/pediatrics/tinea-incognito-urban-pediatric-population
Thomas Stringer, MD, MS, Julia K. Gittler, MD et. al.

Nov 1st, 2018 - Tinea incognito (TI) describes a dermatophytosis with often atypical clinical features attributed to prior use of topical corticosteroids or other immunomodulating agents. Tinea incognito may lack the scale and elevated margin typical of cutaneous.

Product News: 04 2018
https://www.mdedge.com/dermatology/article/163209/product-news-04-2018

Apr 11th, 2018 - Avène Mineral Light Mattifying Sunscreen Lotion Pierre Fabre Dermo-Cosmetique introduces the Avène Mineral Light Mattifying Sunscreen Lotion with SPF 50+. This sunscreen offers broad-spectrum sun protection without irritation while delivering oil.

Woman with rash in groin
https://www.mdedge.com/familymedicine/article/117248/dermatology/woman-rash-groin
The Journal of Family Practice;

Nov 3rd, 2016 - The family physician (FP) suspected that the patient had tinea cruris, but hadn’t ever seen it spread so far from the inguinal area. The rash had central clearing, which is typical of tinea corporis, but is not seen as often with tinea cruris.

see more →

Patient Education  5 results see all →